Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils.

Aging brain·2023
Same author

Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant α-synuclein mice.

Neuroscience letters·2019
Same author

[Mechanisms of Alzheimer's disease : Neuronal hyperactivity and hypoactivity as new therapeutic targets].

Der Nervenarzt·2016
Same author

Monitoring of chronic γ-secretase modulator treatment by serial amyloid-PET.

Molecular psychiatry·2015
Same author

Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment.

Molecular psychiatry·2015
Same author

Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation.

Cell death & disease·2014

Video Experimental Relacionado

Updated: Jul 22, 2026

Purification of Transcripts and Metabolites from Drosophila Heads
12:49

Purification of Transcripts and Metabolites from Drosophila Heads

Published on: March 15, 2013

Patología del Parkinson en una mosca.

C Haass, P J Kahle

    Nature
    |April 4, 2000
    PubMed
    Resumen

    No abstract available in PubMed .

    Más Videos Relacionados

    Mass Histology to Quantify Neurodegeneration in Drosophila
    06:34

    Mass Histology to Quantify Neurodegeneration in Drosophila

    Published on: December 15, 2016

    Measuring Constipation in a Drosophila Model of Parkinson's Disease
    03:20

    Measuring Constipation in a Drosophila Model of Parkinson's Disease

    Published on: September 22, 2023

    Videos de Experimentos Relacionados

    Last Updated: Jul 22, 2026

    Purification of Transcripts and Metabolites from Drosophila Heads
    12:49

    Purification of Transcripts and Metabolites from Drosophila Heads

    Published on: March 15, 2013

    Mass Histology to Quantify Neurodegeneration in Drosophila
    06:34

    Mass Histology to Quantify Neurodegeneration in Drosophila

    Published on: December 15, 2016

    Measuring Constipation in a Drosophila Model of Parkinson's Disease
    03:20

    Measuring Constipation in a Drosophila Model of Parkinson's Disease

    Published on: September 22, 2023